Kolexia
Allavena Clotilde Biologie médicale
Allavena Clotilde
Biologie médicale
Hôpital Hôtel-Dieu Nantes
Nantes, France
189 Activités
45 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Syndrome d'immunodéficience acquise Hépatite C Hépatite Co-infection Diabète Insuffisance rénale chronique Fragilité Hépatite B chronique

Collaborateurs

Voir plus
Raffi Francois
Raffi Francois
Hôpital Hôtel-Dieu Nantes, Nantes, France
Pugliese Pascal
Pugliese Pascal
Hôpital De l'Archet, Nice, France
Rey David
Rey David
Hôpital Civil, Strasbourg, France
Katlama Christine
Katlama Christine
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
ViiV Healthcare
45 collaboration(s)
Dernière en 2023
Gilead
23 collaboration(s)
Dernière en 2023
MSD
13 collaboration(s)
Dernière en 2023
Janssen
11 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Real-world effectiveness of Dolutegravir + Lamivudine (DTG + 3TC) in treatment-naive people with HIV-1 (PWH) and low CD4+ cell count or high viral load at baseline: A systematic literature review
HIV medicine Congress 2023   01 décembre 2023
Acceptability and health-related quality of life among HIV patients switching to a dual therapy with DTG/3TC: Results from PROBI study
HIV medicine Congress 2023   01 décembre 2023
Cabotegravir-rilpivirine long acting: Data in real life setting in a large French cohort
HIV medicine Congress 2023   01 décembre 2023
One-year frailty transitions among persons living with HIV aged 70 years or more on ART
HIV medicine Congress 2023   01 décembre 2023
ANRS 177 DUETTO randomized, open-label and multicentric trial evaluating the non-inferiority of maintenance antiretroviral dual therapy taken 4 consecutive days per week versus dual therapy 7/7 days per week
HIV medicine Congress 2023   01 décembre 2023
Perceived benefits of long-acting injectable antiretroviral treatment go beyond pill-burden relief: Aqualitative study (PANTER)
HIV medicine Congress 2023   01 décembre 2023
Systematic literature review of real-world experience with the 2-drug regimen dolutegravir + lamivudine (DTG + 3TC) in people with HIV-1 (PWH) aged ≥50 years
HIV medicine Congress 2023   01 décembre 2023
Penetration of doravirine combined to raltegravir in semen: Preliminary results of the DORAL switch study
HIV medicine Congress 2023   01 décembre 2023
Assistance and/or autonomy, two principles supporting long-acting injectable antiretroviral treatment administrations in France: A qualitative study (PANTER)
HIV medicine Congress 2023   01 décembre 2023